Technology Strategies Empowering the Clinical Trial Site of the Future

This IDC Perspective examines the technology strategies that will empower the clinical trial site of the future. It maps the key challenges sites face today (burden, recruitment, fragmented data), the evolving technologies reshaping site operations (GenAI; agentic AI; econsent, esource, and EHR-to-EDC interoperability; and unified eclinical platforms), and the perceived risks (data integrity, bias, privacy, equity, and hallucinations) that gate scale. It profiles a representative vendor landscape and looks ahead to disruptive capabilities, from self-driving trials to digital twins to point-of-care research. "The trial site of the future will be defined less by any single tool and more by how well sites transition from the existing 'point-solution tsunami' to unified AI-enabled platforms and by how technology disappears into clinical workflows, freeing site teams to focus on patients," says Dr. Nimita Limaye, research vice president, Life Sciences R&D Strategy and Technology at IDC.